Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 31, 2024
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia
Sujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.
Antimicrobial Agents and Chemotherapy
|
August 30, 2017
Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters
Elizabeth A Lakota, Justin C Bader, Voon Ong, et al.
Antimicrobial Agents and Chemotherapy
|
April 29, 2020
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data
Elizabeth A Lakota, Scott A Van Wart, Michael Trang, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy
|
September 18, 2013
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Open Forum Infectious Diseases
|
September 4, 2024
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis
Sujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2010
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model
Stanley C Gill, Christopher M Rubino, Jennifer Bassett, et al.
Antimicrobial Agents and Chemotherapy
|
November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
David Melnick, Angela K Talley, Vipul K Gupta, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Antimicrobial Agents and Chemotherapy
|
July 31, 2024
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia
Sujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.
Antimicrobial Agents and Chemotherapy
|
August 30, 2017
Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters
Elizabeth A Lakota, Justin C Bader, Voon Ong, et al.
Antimicrobial Agents and Chemotherapy
|
April 29, 2020
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data
Elizabeth A Lakota, Scott A Van Wart, Michael Trang, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy
|
September 18, 2013
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Open Forum Infectious Diseases
|
September 4, 2024
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis
Sujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2010
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model
Stanley C Gill, Christopher M Rubino, Jennifer Bassett, et al.
Antimicrobial Agents and Chemotherapy
|
November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
David Melnick, Angela K Talley, Vipul K Gupta, et al.
Page
of 7